New sphincter implant shows promise for Post-Prostate surgery leakage
NCT ID NCT04088331
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested an artificial urinary sphincter implant in 145 men with stress urinary incontinence after prostate surgery. The device is designed to mimic natural bladder control by opening and closing the urethra. Researchers measured how many men had at least a 50% reduction in urine leakage after 12 months. The study also tracked complications and the need for device revisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AMS 800 Artificial Urinary Sphincter (implantable device)
What this could lead to
If successful, this device could offer a reliable, long-term way to control urinary leakage in men after prostate surgery, improving quality of life.
What could go wrong
The device requires surgery to implant and may need revision or cause complications like infection or device malfunction. Results may not apply to all men with incontinence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STRESS URINARY INCONTINENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Australian Urology Associates
Melbourne, Victoria, 3144, Australia
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Concord Repatriation General Hospital
Concord, New South Wales, 2139, Australia
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
-
Lahey Clinic Hospital
Burlington, Massachusetts, 01805, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
The Methodist Hospital Research Institute
Houston, Texas, 77030, United States
-
University of California, San Francisco
San Francisco, California, 94110, United States
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
-
University of Kansas Hospital
Kansas City, Kansas, 66160-7234, United States
-
University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
Urology San Antonio Research, PA.
San Antonio, Texas, 78229, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27103, United States
-
Willis-Knighton Bossier Medical Center
Bossier City, Louisiana, 71111, United States